Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 82

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 82
---
 year ended December 31, 2024

$: U.S. Dollar

-102-

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ZAI LAB LIMITEDDate: February 27, 2025By:/s/ Samantha (Ying) DuName:Samantha (Ying) DuTitle:Chief Executive Officer

-103-

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated below: 

SignatureTitleDate/s/ Samantha (Ying) DuChief Executive Officer and Chairperson of the Board of DirectorsFebruary 27, 2025Samantha (Ying) Du(Principal Executive Officer)/s/ Yajing ChenChief Financial OfficerFebruary 27, 2025Yajing Chen(Principal Financial and Accounting Officer)/s/ John DiekmanDirectorFebruary 27, 2025John Diekman/s/ Richard GaynorDirectorFebruary 27, 2025Richard Gaynor/s/ Nisa LeungDirectorFebruary 27, 2025Nisa Leung/s/ William LisDirectorFebruary 27, 2025William Lis/s/ Leon O. Moulder, Jr.DirectorFebruary 27, 2025Leon O. Moulder, Jr./s/ Scott MorrisonDirectorFebruary 27, 2025Scott Morrison/s/ Michel VounatsosDirectorFebruary 27, 2025Michel Vounatsos/s/ Peter WirthDirectorFebruary 27, 2025Peter Wirth

-104-

Zai Lab Limited

Index to Consolidated Financial Statements

PageReports of Independent Registered Public Accounting Firms (KPMG LLP, Short Hills, NJ, Auditor Firm ID: 185) F-2Consolidated Balance Sheets as of December 31, 2024 and 2023F-5Consolidated Statements of Operations for the Years Ended December 31, 2024, 2023, and 2022F-6Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2024, 2023, and 2022F-7Consolidated Statements of Shareholders’ Equity for the Years Ended December 31, 2024, 2023,